The ruling does not address the legality of selling consumable delta-8 THC products and does not alter state laws.Read More
The hemp-derived active ingredients provider is expected to more than double 22nd Century’s revenue.Read More
There are currently three bills in the U.S. Congress that are competing to legalize federal marijuana.Read More
The MORE Act would remove marijuana from the list of federally controlled substances, among other items.Read More
The judge issued a 30-day order restraining a local DA from prosecuting people for selling extracts.Read More
The cannabis plant transformation breakthrough was unlocked by 22nd Century and KeyGene.Read More
Germany’s new government plans to legalize cannabis to consumers over 18 for recreational purposes.Read More
Turning Point Brands is embracing next-gen tobacco and alternative products by taking calculated risks.Read More
Regulators recalled the THC products because the state says ingredients are unapproved for inhalation.Read More
The company is no longer involved in industrial hemp or CBD activities, according to a statement.Read More
